Latest Dividend Declarations News

Timah Resources Limited reported a 13% revenue decline in H1 2025, impacted by a significant flashover incident at its Biogas Power Plant that disrupted power exports and delayed operations.

Aerometrex Limited’s FY2025 results reveal a sharp decline in net tangible asset backing and a widening loss, signaling challenges ahead for the aerial imaging specialist.

Jupiter Mines has declared a final unfranked dividend of 0.75 cents per share for H2 FY2025, reflecting a solid payout ratio amid fluctuating earnings and Tshipi dividend receipts.

K2 Asset Management posted a 17% revenue increase and returned to profitability in FY25, declaring a fully franked dividend and signalling plans for mergers and acquisitions to accelerate expansion.

K2 Asset Management Holdings Ltd has reported a strong financial year ending June 2025, with revenues up 17% and a return to profitability, alongside a fully franked dividend declaration.

Hearts and Minds Investments Limited (HM1) reported a stellar FY25 with total comprehensive income soaring to $124.8 million, nearly doubling the prior year, alongside a dividend increase and sustained philanthropic commitments.

Boss Energy reported a sharp turnaround with a $34.2 million net loss for FY2025 despite generating $75.6 million in revenue, while withholding dividends amid ongoing challenges.

Pathkey.AI Ltd reported a substantial reduction in its annual loss to $1.45 million for FY2025, despite a dramatic 93% plunge in revenue to just $27,783. The company’s financials reveal a cautious recovery phase with significant equity injections and a new cryptocurrency investment.

Vection Technologies reported a 9.6% revenue increase to $36 million and a 25.3% reduction in net loss for FY2025, driven by operational improvements and a key acquisition.

The Calmer Co. International Limited reported a strong revenue increase of 88% for the year ended June 2025, yet the company still recorded a net loss of nearly $4 million, with no dividends declared.

Visionflex Group Limited reported a sharp 33% decline in revenues and a 69% increase in net losses for FY25, with auditors flagging material uncertainty over the company’s ability to continue as a going concern.

Island Pharmaceuticals reported a $3.92 million loss for FY2025 despite an 86% increase in income, with no dividends declared.